久久一区二区三区四区_欧美高清dvd_日韩欧美在线看_国产精品欧美一区二区_av天天看_欧美精品免费观看二区

美國Echelon Biosciences
Echelon 于1997 年在美國猶他州成立，其前身是美國國家級細胞信號研究中心。Echelon 提供各種抗體、分析檢測試劑盒、抑制劑等產品，尤其擅長以細胞信號、脂類代謝和標記物研究為主的相關產品。為研究治療諸如癌癥、糖尿病、炎癥、感染和心腦血管疾病專家提供全面有效工具。
Echelon Biosciences was formed from a project under the Center for Cell Signaling, a State of Utah Center of Excellence, and was incorporated under the laws of the state of Utah as Echelon Research Laboratories, Inc. on October 3, 1997. The company has since changed its name to Echelon Biosciences Incorporated. The company was organized to further the science of lipid cell signaling and critical metabolic enzymes, which provide new and viable targets for the development of potential drugs and diagnostics for cancer, diabetes, inflammation, infections, and cardiovascular disease.

From 1997 through 2004 Echelon primarily used government grants and product sales revenues to fund its research efforts. In early 2005 Echelon was purchased by Aeterna Zentaris (NAS: AEZS) for its MEP antiinfectives, PI 3-Kinase small molecule program and catalog business.

In late 2007, Echelon was acquired by Frontier Scientific Inc. Frontier is based in Logan, Utah; specializing in Porphyrin and related compounds and Photo Dynamic Therapy. The new ownership allows expanded research and funding for many positive aspects for both Echelon and Frontier.